Interestingly, relaxin-2 exerts an anti-inflammatory effect by decreasing IL-6 mRNA expression and plasma levels in rat left ventricle and infarcted myocardium as well as in apolipoprotein E-deficient mice model of atherosclerosis [111,115,166]. This evidence concerns the gene RLN2 and atherosclerosis.